drugset / Trial / NCT01235819
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
RandomizedParallel-groupOpen-labelTreatment
Summary
To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detected type 1 diabetes patients.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Exenatide | Peptide | 10 ug | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |
| Comparator | Insulin | Protein / enzyme biologic | — | — |